<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/190</identifier>
				<datestamp>2024-10-30T19:16:03Z</datestamp>
				<setSpec>aavptbiennial:S1</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Impairment of Homeostasis in Airway Smooth Muscle by Pulmonary Infection</dc:title>
	<dc:creator xml:lang="en">Conlon, P. D.</dc:creator>
	<dc:subject xml:lang="en">upper respiratory tract infections</dc:subject>
	<dc:subject xml:lang="en">asthma</dc:subject>
	<dc:subject xml:lang="en">bronchospastic agents</dc:subject>
	<dc:subject xml:lang="en">histamine</dc:subject>
	<dc:description xml:lang="en">In humans, it is known that upper respiratory tract infections frequently exacerbate, or precipitate, asthma, and that they also increase airway reactivity to bronchospastic agents. Szentivanyi proposed that an autonomic nervous system imbalance characterized by a diminished beta adrenergic response of bronchial smooth muscle was important in the pathogenesis of asthma (1). It has been shown previously that mice vaccinated with Bordetella pertussis were hyperreactive to histamine and other mediators (2), and that this hyperreactivity resembled that seen in asthmatics. Szentivanyi also showed that pertussis-vaccinated mice have decreased metabolic responses to catecholamines (3). Findings of decreased biochemical and physiological responses to beta adrenergic drugs in human asthmatics support Szentivanyi's proposal (4,5,6,7). </dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/190</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 13-18</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/190/181</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
